Medplum vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
"Firebase for healthcare" open-source FHIR EHR API infrastructure; YC S22 $550K with $1.2M revenue serving thousands of health tech developers competing with Google Cloud Healthcare API for HIPAA-compliant infrastructure.
About
Medplum is a San Francisco-based open-source EHR and healthcare API infrastructure company — often described as "Firebase for healthcare" — providing FHIR-compliant API infrastructure, clinical data management, and workflow tools that healthcare developers use to build EMR-adjacent applications, care management platforms, and health tech products without building from scratch the compliance, data modeling, and interoperability layers that healthcare applications require. Founded in 2021 and backed by Y Combinator (S22) with $550,000 raised, Medplum achieved $1.2 million in revenue in 2024 serving thousands of developers globally building on the open-source platform.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.